(Q40433308)

20 September 2017

1 reference

title

Immunity to oncogenic proteins (English)

1 reference

20 September 2017

Immunity to Oncogenic Proteins (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

30 May 2024

author name string

M. A. Cheever

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590829

30 May 2024

M. L. Disis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590829

30 May 2024

H. Bernhard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590829

30 May 2024

J. R. Gralow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590829

30 May 2024

S. L. Hand

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590829

30 May 2024

E. S. Huseby

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590829

30 May 2024

H. L. Qin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590829

30 May 2024

M. Takahashi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590829

30 May 2024

W. Chen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590829

30 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7590829

30 May 2024

publication date

1 June 1995

1 reference

full work available at URL

20 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-065X.1995.tb00076.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-065X.1995.tb00076.x

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

30 May 2024

published in

Immunological Reviews

1 reference

20 September 2017

volume

145

1 reference

20 September 2017

page(s)

33-59

1 reference

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Using a neural network to identify potential HLA-DR1 binding sites within proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Biological and biochemical properties of human rasH genes mutated at codon 61.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Identifying antigenic T-cell sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Cancer antigens: immune recognition of self and altered self

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Cytotoxic T Cells Isolated from Ovarian Malignant Ascites Recognize a Peptide Derived from the HER-2/neu Proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

T cell recognition of human tumors: implications for molecular immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

The role of erbB-2 and its ligands in growth control of malignant breast epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

In vitro and in vivo release of soluble erbB-2 protein from human carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Biological properties of human c-Ha-ras1 genes mutated at codon 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Antibody recognition of the tumor-specific bcr-abl joining region in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

Prevalence of ras gene mutations in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00076.X

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector

30 May 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

ras oncogenes in human cancer: a review

30 May 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

T-cell immunity to the joining region of p210BCR-ABL protein

30 May 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

30 May 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

Cytotoxic T-cell response and in vivo protection against tumor cells harboring activated ras proto-oncogenes

30 May 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

A K-ras 13Gly-->Asp mutation is recognized by HLA-DQ7 restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers harbouring this mutation?

30 May 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly-->Asp).

30 May 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides

30 May 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

T cell clones specific for p21 ras-derived peptides: characterization of their fine specificity and HLA restriction

30 May 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA.

30 May 2024

35

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization

30 May 2024

46

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

The neu-oncogene product in serum and tissue of patients with breast carcinoma

30 May 2024

47

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients

30 May 2024

50

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

Anti-peptide antibodies detect oncogene-related proteins in urine

30 May 2024

56

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

30 May 2024

A new look for the 1990s

57

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

Induction of T cells specific for the mutated segment of oncogenic P21ras protein by immunization in vivo with the oncogenic protein

30 May 2024

60

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

30 May 2024

61

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

Dominance and crypticity of T cell antigenic determinants

30 May 2024

67

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

30 May 2024

68

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

30 May 2024

69

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

Three human transforming genes are related to the viral ras oncogenes

30 May 2024

70

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides

30 May 2024

71

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00076.X

30 May 2024

Identifiers

1 reference

20 September 2017

1 reference